An International survey on living kidney donation and transplant practices during the COVID-19 pandemic.

Autor: Salvalaggio PR; Department of Surgery Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Ferreira GF; Department of Medicine, Santa Casa de Juiz de Fora, Juiz de Fora, Brazil., Caliskan Y; Saint Louis University Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, USA., Vest LS; Saint Louis University Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, USA., Schnitzler MA; Saint Louis University Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, USA., de Sandes-Freitas TV; Department of Medicine, Universidade Federal do Ceara, Fortaleza, Brazil., Moura LR; Department of Medicine, Universidade Federal de Sao Paulo, Sao Paulo, Brazil., Lam NN; Department of Medicine, University of Calgary, Calgary, AB, Canada., Maldonado RA; Department of Medicine, Clinica Privada Vélez Sarsfield, Córdoba, Argentina., Loupy A; Department of Medicine, Necker Hospital, Paris, France., Axelrod DA; Department of Surgery, University of Iowa, Iowa City, IA, USA., Lentine KL; Saint Louis University Center for Abdominal Transplantation, Saint Louis University, St. Louis, MO, USA.
Jazyk: angličtina
Zdroj: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2021 Apr; Vol. 23 (2), pp. e13526. Date of Electronic Publication: 2020 Dec 19.
DOI: 10.1111/tid.13526
Abstrakt: The scope of the impact of the Coronavirus disease 19 (COVID-19) pandemic on living donor kidney transplantation (LDKT) practices across the world is not well-defined. We received survey responses from 204 transplant centers internationally from May to June 2020 regarding the impact of the COVID-19 pandemic on LDKT practices. Respondents represented 16 countries on five continents. Overall, 75% of responding centers reported that LDKT surgery was on hold (from 67% of North American centers to 91% of European centers). The majority (59%) of centers reported that new donor evaluations were stopped (from 46% of North American centers to 86% of European centers), with additional 23% of centers reporting important decrease in evaluations. Only 10% of centers reported slight variations on their evaluations. For the centers that continued donor evaluations, 40% performed in-person visits, 68% by video, and 42% by telephone. Center concerns for donor (82%) and recipient (76%) safety were the leading barriers to LDKT during the pandemic, followed by patients concerns (48%), and government restrictions (46%). European centers reported more barriers related to staff limitations while North and Latin American centers were more concerned with testing capacity and insufficient resources including protective equipment. As LDKT resumes, 96% of the programs intend to screen donor and recipient pairs for coronavirus infection, most of them with polymerase chain reaction testing of nasopharyngeal swab samples. The COVID-19 pandemic has had broad impact on all aspects of LDKT practice. Ongoing research and consensus-building are needed to guide safe reopening of LDKT programs.
(© 2020 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje